Optimization of CAR-Bacteria for Oral Cancer
口腔癌 CAR 细菌的优化
基本信息
- 批准号:10648292
- 负责人:
- 金额:$ 22.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-15 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AffinityAnimal ModelAntigen TargetingBacteriaBilateralBindingCell DeathCell LineCellsCervicalComplexCytolysisDataDoseEngineeringEngraftmentEvolutionFutureGoalsGrowthHLA-A2 AntigenHead and Neck CancerHumanHuman Cell LineHuman PapillomavirusInnate Immune ResponseKineticsLabelLibrariesMajor Histocompatibility ComplexMalignant NeoplasmsMalignant neoplasm of cervix uteriMeasuresMediatingMethodsMolecular EvolutionMouthwashMusOncoproteinsPatternPeptide/MHC ComplexPeptidesPharmaceutical PreparationsPhysiologic pulsePopulation DensityProductionProteinsResearchSpecificityT-LymphocyteTherapeuticToxic effectTreatment EfficacyTumor Specific PeptideViralWorkXenograft Modelantigen challengecancer cellchimeric antigen receptorexperimental studyhuman modelimprovedin vivoinnovationintraperitonealinventionknock-downmalignant mouth neoplasmnanobodiesneoplastic cellnoveloral bacteriaoverexpressionpreventresponsesystemic toxicitytechnology platformtumortumor growthtumor immunology
项目摘要
ABSTRACT
The goal of this project is to explore the feasibility of generating Chimeric Antigen Receptors (CARs)
expressed by bacteria. Instead of using T cells, we propose to explore the idea and use of bacteria to mediate
the targeted destruction of cancer cells. In addition, we explore the possibility that we could target CAR-bacteria
to specific major histocompatibility complex (MHC)-neopeptide complexes (pMHC) on tumor cells. We call these
engineered bacteria cells CAR-bacteria. Current CAR-expressing T cells provide durable responses but have
three main limitations: specificity, toxicity, and feasibility. This study will address all three concerns. In this
proposal, we target engineered bacterial lysis to head and neck or cervical cancer cells expressing HLA-A2-E7,
a known pMHC on tumor cells infected by human papilloma virus (HPV). The targeting enables anti-tumor protein
production only when a predefined population density of bacteria is reached. This method should dramatically
reduce bacterial colony size and greatly lowers/prevents systemic toxicities. The approach has the potential to
be a therapeutic in HPV-positive oral cancer as it could be administered and controlled as a bacterial mouthwash.
This project combines two innovations leveraging a Synthetically-Evolved Nanobody (SEN) library proven
capable of selectively binding MHC-peptide complexes and combining this specific cancer cell targeting with
synchronized circuit lysis to create CAR-bacteria. Our proposed studies provide proof-of-concept that (1) CARs
can be produced that recognize pMHC, (2) CAR-bacteria localization and colonization can be controlled by tumor
expression of certain pMHC and (3) CAR-bacteria have therapeutic activity against tumor cells that express
specific pMHC. We accomplish these proof-of-concept studies via the following two objectives: (1) Optimize
binding and specificity of CAR-bacteria to HLA-A2-E7 and (2) Check efficacy of CAR-bacteria in an animal model
of head and neck and cervical cancer.
抽象的
该项目的目标是探索生成嵌合抗原受体(CAR)的可行性
由细菌表达。我们建议不使用 T 细胞,而是探索细菌介导的想法和用途
有针对性地破坏癌细胞。此外,我们还探索了针对 CAR 细菌的可能性
肿瘤细胞上特定的主要组织相容性复合物(MHC)-新肽复合物(pMHC)。我们称这些为
工程细菌细胞CAR-细菌。目前表达 CAR 的 T 细胞可提供持久的反应,但
三个主要局限性:特异性、毒性和可行性。这项研究将解决所有三个问题。在这个
建议,我们针对表达 HLA-A2-E7 的头颈或宫颈癌细胞进行工程细菌裂解,
已知的 pMHC 与人乳头瘤病毒 (HPV) 感染的肿瘤细胞有关。靶向使抗肿瘤蛋白成为可能
仅当达到预定的细菌种群密度时才进行生产。该方法应该显着
减少细菌菌落大小并大大降低/防止全身毒性。该方法有潜力
可以作为 HPV 阳性口腔癌的治疗剂,因为它可以作为细菌漱口水进行施用和控制。
该项目结合了两项创新,利用经过验证的合成进化纳米抗体 (SEN) 库
能够选择性地结合 MHC-肽复合物,并将这种特定的癌细胞靶向与
同步电路裂解以产生 CAR 细菌。我们提出的研究提供了以下概念验证:(1) CAR
可以生产识别pMHC,(2)CAR-细菌定位和定植可以由肿瘤控制
(3) CAR-细菌对表达某些 pMHC 的肿瘤细胞具有治疗活性
特异性 pMHC。我们通过以下两个目标完成这些概念验证研究:(1) 优化
CAR-细菌与 HLA-A2-E7 的结合和特异性以及 (2) 检查 CAR-细菌在动物模型中的功效
头颈癌和宫颈癌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jack D Bui其他文献
Jack D Bui的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jack D Bui', 18)}}的其他基金
Modeling human trophoblast-NK cell interactions in term and preterm birth
足月和早产时人类滋养层 - NK 细胞相互作用的建模
- 批准号:
10770207 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Modeling human trophoblast-NK cell interactions in term and preterm birth
足月和早产时人类滋养层 - NK 细胞相互作用的建模
- 批准号:
10211100 - 财政年份:2021
- 资助金额:
$ 22.16万 - 项目类别:
Modeling human trophoblast-NK cell interactions in term and preterm birth
足月和早产时人类滋养层 - NK 细胞相互作用的建模
- 批准号:
10549321 - 财政年份:2021
- 资助金额:
$ 22.16万 - 项目类别:
Modeling human trophoblast-NK cell interactions in term and preterm birth
足月和早产时人类滋养层 - NK 细胞相互作用的建模
- 批准号:
10370386 - 财政年份:2021
- 资助金额:
$ 22.16万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




